| 000 | 01737 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516034216.0 | ||
| 264 | 0 | _c20110805 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.110.610147 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmadja, Didier | |
| 245 | 0 | 0 |
_aA new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients. _h[electronic resource] |
| 260 |
_bStroke _cJun 2011 |
||
| 300 |
_a1644-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xdrug therapy |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 | _aTenecteplase |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChausson, Nicolas | |
| 700 | 1 | _aJoux, Julien | |
| 700 | 1 | _aSaint-Vil, Martine | |
| 700 | 1 | _aSignaté, Aïssatou | |
| 700 | 1 | _aEdimonana, Mireille | |
| 700 | 1 | _aJeannin, Séverine | |
| 700 | 1 | _aBartoli, Blaise | |
| 700 | 1 | _aAveillan, Mathieu | |
| 700 | 1 | _aCabre, Philippe | |
| 700 | 1 | _aOlindo, Stéphane | |
| 773 | 0 |
_tStroke _gvol. 42 _gno. 6 _gp. 1644-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.110.610147 _zAvailable from publisher's website |
| 999 |
_c20792347 _d20792347 |
||